Recherche
Radiobiology for Targeted and Personalized Radiotherapy : Jean-Pierre POUGET & David AZRIA

Simon L, Constanzo J, Terraza-Aguirre C, Ibn Elfekih Z, Berthelot J, Benkhaled B, Haute T, Pednekar K, Clark K, Emerson S, Atis S, Benedetti C, Langlois S, Marquant A, Prakash J, Wang A, Devoisselle J, Montier T, Djouad F, Pouget J, Lapinte V, Morille M Surface modification of extracellular vesicles with polyoxazolines to enhance their plasma stability and tumor accumulation. Biomaterials. 2025;313. doi:10.1016/j.biomaterials.2024.122748

Laurent P-A, André F, Bobard A, Demaria S, Depil S, Eichmüller S, Fernandez-Palomo C, Foijer F, Galluzzi L, Guckenberger M, Harrington K, Herrera F, Huber P, Italiano A, Karam S, Kroemer G, Lambin P, Leuschner C, Mantovani A, Meylan E, Mondini M, Pittet M, Pouget J-P, Remon J, Sørensen C, Sotiriou C, Vanpouille-Box C, Weichselbaum R, Welsh J, Zitvogel L, Formenti S, Deutsch E Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference. Oncoimmunology. 2025;14(1):2432726. doi:10.1080/2162402X.2024.2432726

MHC-I-driven anti-tumor immunity counterbalances low absorbed doses of targeted radionuclide therapy. J Nucl Med. 2025 (in press).

Rubira L, Donzé C, Fouillet J, Algudo B, Kotzki P, Deshayes E, Fersing C [68Ga]Ga-FAPI-46 synthesis on a GAIA® module system: Thorough study of the automated radiolabeling reaction conditions. Appl Radiat Isot. 2024;206. doi:10.1016/j.apradiso.2024.111211

Souche C, Fouillet J, Rubira L, Donzé C, Sallé A, Dromard Y, Deshayes E, Fersing C Towards Optimal Automated 68Ga-Radiolabeling Conditions of the DOTA-Bisphosphonate BPAMD Without Pre-Purification of the Generator Eluate. J Labelled Comp Radiopharm. 2024-11-20. doi:10.1002/jlcr.4128

Bardiès M, Flux G, Sjögreen Gleisner K The Translation of Dosimetry into Clinical Practice: What It Takes to Make Dosimetry a Mandatory Part of Clinical Practice. J Nucl Med. 2024;65(12):1846-1847. doi:10.2967/jnumed.124.267742

Bardiès M, Flux G, Platoni P, Koutsouveli E Symposium on molecular radiotherapy dosimetry: The first of a series?. Phys Med. 2024;120. doi:10.1016/j.ejmp.2024.103328

Pastre M, Occéan B-V, Boudousq V, Conejero I, Fabbro-Peray P, Collombier L, Mallet L, Lopez-Castroman J Serotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findings. Psychiatry Clin Neurosci. 2024-11-07. doi:10.1111/pcn.13760

Kayal G, Barbosa N, Marín C, Ferrer L, Fragoso-Negrín J-A, Grosev D, Gupta S, Hidayati N, Moalosi T, Poli G, Thakral P, Tsapaki V, Vauclin S, Vergara-Gil A, Knoll P, Hobbs R, Bardiès M Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study. J Nucl Med. 2024;65(1):125-131. doi:10.2967/jnumed.122.265340

Combet-Curt V, Buchalet C, Le Malicot K, Lemanski C, Deshayes E, Bonichon-Lamichhane N, Lièvre A, Huguet F, Tlili G, Vendrely V Prognostic Value of 18F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE. J Nucl Med. 2024;65(8):1194-1201. doi:10.2967/jnumed.124.267626

Gong K, Magnier B, L'hostis S, Borrely F, Le Bon S, Mamou A, Kotzki P, Boudousq V Predicting Response to [177Lu]Lu-PSMA Therapy in mCRPC Using Machine Learning. J Pers Med. 2024;14(11):1068. doi:10.3390/jpm14111068

Poty S, Ordas L, Dekempeneer Y, Parach A, Navarro L, Santens F, Dumauthioz N, Bardiès M, Lahoutte T, D'Huyvetter M, Pouget J-P Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting. J Nucl Med. 2024;65(10):1564-1570. doi:10.2967/jnumed.124.267624

Hébert K, Bodin-Cufi P, Fersing C, Deshayes E New Drugs for Targeted Radionuclide Therapy in Metastatic Prostate Cancer. Eur Urol Focus. 2024;10(4):514-517. doi:10.1016/j.euf.2024.07.016

Maïmoun L, Aouinti S, Puech M, Lefebvre P, Humbert L, Deloze M, de Santa Barbara P, Maïmoun-Nande L, Boudousq V, Cristol J-P, Renard E, Picot M-C, Mariano-Goulart D, Nocca D Modification of bone architecture following sleeve gastrectomy: a 5-year follow-up. J Bone Miner Res. 2024-12-18. doi:10.1093/jbmr/zjae202

Guillemard S, Moulis L, Ilonca D, Mestre S, Deshayes E, Quéré I, Adham S LYMPHOSCORE (Lymphoscintigraphy Scoring Reliability) Reliability of a New Qualitative and Semiquantitative Lymphoscintigraphy Scoring System for Primary Lymphedema. Clin Nucl Med. 2024;49(9):e428-e435. doi:10.1097/RLU.0000000000005357

Peters S, Tran-Gia J, Agius S, Ivashchenko O, Badel J, Cremonesi M, Kurth J, Richetta E, Gleisner K, Tipping J, Bardiès M, Stokke C Implementation of dosimetry for molecular radiotherapy; results from a European survey. Phys Med. 2024;117. doi:10.1016/j.ejmp.2023.103196

Constanzo J, Pouget J-P Extracellular vesicles role in radio(nuclide)therapy. J Radiat Res. 2024;65(Supplement_1):i6-i14. doi:10.1093/jrr/rrae084

Pouget J-P, Gabina P, Herrmann K, Deandreis D, Konijnenberg M, van Leeuwen F, Kurth J, Eberlein U, Lassmann M, Lückerath K EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses. Eur J Nucl Med Mol Imaging. 2024-11-12. doi:10.1007/s00259-024-06963-9

Santoro L, Monnier M, Castan F, Berkane I, Fersing C, Gélibert P, Pouget J-P, Bardiès M, Kotzki P-O, Deshayes E Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine. J Nucl Med. 2024;65(6):923-930. doi:10.2967/jnumed.123.267023

Fouillet J, Donzé C, Deshayes E, Santoro L, Rubira L, Fersing C "One Method to Label Them All": A Single Fully Automated Protocol for GMP-Compliant 68Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617. Curr Radiopharm. 2024;17(3):285-301. doi:10.2174/0118744710293461240219111852

Belkacemi Y, Debbi K, Besnard C, Grellier N, Fonteneau G, Colson-Durand L, Lerouge D, Durdux C, Campana F, Pons P, Flandin I, Pasquier D, de Crevoisier R, Wachter T, Thureau S, Conzague-Casabianca L, Petit A, Supiot S, Azria D [The morbidity and mortality review meetings in radiotherapy departments: Procedure, implementation and prospects of the "Proust" French national project]. Cancer Radiother. 2023;27(6-7):474-479. doi:10.1016/j.canrad.2023.06.018

Marguerit A, Azria D, Riou O, Demontoy S, Thezenas S, Boisselier P [Stereotactic Body Radiation Therapy for less than 3cm (stage I) and 5cm (stage II) inoperable lung tumors: 10 years experience of Montpellier Cancer Institute]. Cancer Radiother. 2023;27(5):387-397. doi:10.1016/j.canrad.2023.05.002

Hanslik N, Bourgier C, Thezenas S, Firmin N, Riou O, Azria D, Llacer-Moscardo C [Predictive factors assessment of pathological response to neoadjuvant radiotherapy of soft tissue sarcomas]. Cancer Radiother. 2023-10-07. doi:10.1016/j.canrad.2023.02.003

Legouté F, Lesueur P, El Kabbaj O, Ghannam Y, Michalet M, Monpetit E, Azria D, Giraud P, Calais G, Pointreau Y, Ollivier L [French careers in oncology radiotherapy: Crossing views]. Cancer Radiother. 2023;27(1):75-79. doi:10.1016/j.canrad.2022.07.016

Bruneaux E, Iborra F, Trouche-Sabatier S, Foucan A, Gras-Aygon C, Poinas G, Azria D, Trétarre B [Bladder tumors in the Hérault department: Results of the Hérault tumor registry registration from1987 to 2019]. Prog Urol. 2023-08-28. doi:10.1016/j.purol.2023.08.015



© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés